Skip to main content
Clinical Trials/NL-OMON54080
NL-OMON54080
Recruiting
Phase 3

ltrasound-guided Radiofrequency Ablation versus radioactive iodine as Treatment for Hyperthyroidism caused by Solitary Autonomous Thyroid Nodules - RABITO study

Rijnstate Ziekenhuis0 sites232 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
hyperactive nodule
Sponsor
Rijnstate Ziekenhuis
Enrollment
232
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Rijnstate Ziekenhuis

Eligibility Criteria

Inclusion Criteria

  • \- Age \> 18 years
  • \- Hyperthyroidism or subclinical hyperthyroidims caused by a solitary
  • hyperactive thyroid nodule (HTN), either located in an otherwise normal thyroid
  • gland, or in a multinodular goitre (MNG)
  • \- Treatment with RAI indicated and eligible for RFA
  • \- Signed informed consent

Exclusion Criteria

  • \- Multifocal HTN
  • \- HTN \> 50 mm
  • \- Presence of a medical device susceptible to disturbances caused by RFA
  • generated currents
  • \- Patients with physical or behavioural disorders that preclude safe isolation
  • in radiation protection rooms, or safe RFA procedure under local anesthesia
  • \- Uncorrectable hemorrhagic diathesis
  • \- Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials